MONTVALE, N.J., March 22 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that David A. Lowe, Ph.D., Chief Scientific Officer, will be presenting at the following upcoming investor conferences:
Future Leaders in the Biotech Industry Conference on Thursday, March 29, 2007 at 2:30 p.m. Eastern Time at the Millennium Broadway Hotel in New York City. Leerink Swann & Company/MEDACorp Alzheimer's Disease Roundtable Conference on Tuesday, April 3, 2007 at 10:15 a.m. Eastern Time at Le Parker Meridien Hotel in New York City.
Interested parties may access a live audio webcast of the presentations by visiting the "Investors" section of Memory Pharmaceuticals' website at http://www.memorypharma.com. Archived versions of the webcasts will be available at the same location for one week following each of the presentations.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression and bipolar disorder. For additional information, please visit our website at http://www.memorypharma.com.
Memory Pharmaceuticals Corp.CONTACT: Jzaneen Lalani, Vice President, Legal Affairs of MemoryPharmaceuticals Corp., +1-201-802-7249; or Laura Perry of Stern InvestorRelations, Inc., +1-212-362-1200
Web site: http://www.memorypharma.com/
